Patent ID: 11938217
Assignee: SLAYBACK PHARMA LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 2:
3. A stable injectable pharmaceutical composition for reversing effects of non-depolarizing neuromuscular blocking agents in a patient in need thereof, disposed in a pre-filled syringe comprising
(i) neostigmine or a pharmaceutically acceptable salt, solvate or hydrate thereof,
(ii) glycopyrrolate or a pharmaceutically acceptable salt, solvate or hydrate thereof,
(iii) a pharmaceutically acceptable liquid vehicle,
wherein the pharmaceutical composition has a pH ranging from 3.0 to 4.0;
wherein the level of Neostigmine Impurity A in the composition is less than 1% when stored at 40° C. for at least 3 months.